However, during the transition period (day 14) only Il6 remained mildly increased in response to hemarthrosis, and was somewhat suppressed with both FVIII-preparations, indicating lesser inflammation on day 14 (Fig 5D). The gene discussed is IL6; the disease is hemarthrosis.